RIL
CATX icon

Rothschild Investment LLC’s Perspective Therapeutics CATX Stock Holding History

Rothschild Investment LLC’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102 Sell
30
-4
-12% -$15 ﹤0.01% 3513
2026
Q1 		$142 Buy
34
+27
+386% +$114 ﹤0.01% 3356
2025
Q4 		$19 Buy
+7
New +$20 ﹤0.01% 3342
2024
Q4 		– Sell
-55
Closed -$734 – 2970
2024
Q3 		$734 Buy
+55
New +$731 ﹤0.01% 2353

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Rothschild Investment LLC's CATX Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Perspective Therapeutics (CATX) stake by 12% in Q2 2026, selling an estimated $15 and leaving 30 shares worth $102. The position accounts for ﹤0.01% of the portfolio, ranked #3513.

Rothschild Investment LLC first reported a position in CATX in Q3 2024 and has held it in 4 quarters since. The position peaked at $734 in Q3 2024. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Rothschild Investment LLC held 30 shares of Perspective Therapeutics worth $102 as of Q2 2026.
  • Rothschild Investment LLC sold 4 Perspective Therapeutics shares in Q2 2026, an estimated $15.
  • Perspective Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3513 holding.
  • Rothschild Investment LLC first reported a position in Perspective Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • Rothschild Investment LLC's Perspective Therapeutics position peaked at $734 in Q3 2024.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.